Driehaus Capital Management’s Elevance Health ELV Stock Holding History

Driehaus Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-455	Closed	-$237K	–	409
2024 Q3	$237K	Buy	+455	New	+$243K	﹤0.01%	368
2023 Q1	–	Sell	-629	Closed	-$323K	–	403
2022 Q4	$323K	Buy	629 +73	+13%	+$37.1K	﹤0.01%	318
2022 Q3	$253K	Buy	556 +132	+31%	+$63.2K	﹤0.01%	330
2022 Q2	$205K	Buy	+424	New	+$210K	﹤0.01%	347
2018 Q2	–	Sell	-1,158	Closed	-$254K	–	490
2018 Q1	$254K	Sell	1,158 -31	-3%	-$7.28K	0.01%	453
2017 Q4	$268K	Buy	+1,189	New	+$253K	0.01%	480

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Driehaus Capital Management's ELV Position: Q4 2024 in Review

Driehaus Capital Management sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 455 shares — an estimated $237K sold.

Driehaus Capital Management first reported a position in ELV in Q4 2017 and held it in 6 quarters. The position peaked at $323K in Q4 2022. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

Driehaus Capital Management reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
Driehaus Capital Management sold 455 Elevance Health shares in Q4 2024, an estimated $237K.
Driehaus Capital Management first reported a position in Elevance Health in Q4 2017 and held it in 6 quarters.
Driehaus Capital Management's Elevance Health position peaked at $323K in Q4 2022.
1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Driehaus Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.